[CME Answers: 'Mepolizumab, an Additional Therapeutic Agent for Severe Asthma', Praxis No. 21].

[CME Answers: 'Mepolizumab, an Additional Therapeutic Agent for Severe Asthma', Praxis No. 21]. Praxis (Bern 1994). 2018;107(22):1229 Authors: Latshang T PMID: 30376774 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30376774?dopt=Abstract

Source: Praxis - November 1, 2018 Category: General Medicine Authors: Latshang T Tags: Praxis (Bern 1994) Source Type: research

More News: Asthma | General Medicine